Karyopharm Therapeutics
KPTI
#11187
Rank
โ‚ฌ2.1 M
Marketcap
0,09296ย โ‚ฌ
Share price
-84.29%
Change (1 day)
-98.23%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: โ‚ฌ2.1 Million

As of November 2026 Karyopharm Therapeutics has a market cap of โ‚ฌ2.1 Million. This makes Karyopharm Therapeutics the world's 11187th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ2.1 M-98.05%
2025โ‚ฌ0.10 B27.04%
2024โ‚ฌ85 M-5.15%
2023โ‚ฌ89.62 M-75.03%
2022โ‚ฌ0.35 B-16.34%
2021โ‚ฌ0.42 B-53.69%
2020โ‚ฌ0.92 B-17.2%
2019โ‚ฌ1.11 B124.53%
2018โ‚ฌ0.49 B31.98%
2017โ‚ฌ0.37 B2.42%
2016โ‚ฌ0.36 B-15.19%
2015โ‚ฌ0.43 B-56.81%
2014โ‚ฌ1.00 B104.94%
2013โ‚ฌ0.49 B

End of Day market cap according to different sources

On Nov 1st, 2026 the market cap of Karyopharm Therapeutics was reported to be:

โ‚ฌ13.4 Million
by Nasdaq info icon info icon
โ‚ฌ13.4 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
โ‚ฌ171.38 B 8,128,247.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ328.68 B 15,588,344.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ114.97 B 5,452,636.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ15.46 B 733,284.43%๐Ÿ‡บ๐Ÿ‡ธ USA